Clinical & Scientific

Event · Events

Explore subtopics

Breakthrough Designation11CE Mark7Clinical Trial441Drug Application14FDA Approval204Phase 1/2/338Scientific Publication24

Displaying items 181-184 of 184 in total

Sarah Hughes 4 months ago

The New Supply Chain: How Private Partnerships Control Patient Healthcare

A new alliance aims to streamline at-home diagnostics for pharma, but who is accountable for patient data and safety in this rapidly growing market?

Read full article
The New Supply Chain: How Private Partnerships Control Patient Healthcare
Innovation Spotlight: The Future of Business 4 months ago

Biotech's Race Against the Clock: A Cancer Drug vs. the $1 Mark

Intensity Therapeutics has a promising cancer therapy in late-stage trials, but can its scientific innovation outpace a looming Nasdaq delisting threat?

Read full article
Biotech's Race Against the Clock: A Cancer Drug vs. the $1 Mark
Innovation Spotlight: The Future of Business 4 months ago

Immatics' $125M Raise: Fueling a New Wave of Cancer Therapies

Immatics just secured $125M. This cash infusion is a major bet on its pioneering PRAME-targeted therapies and a key signal for the future of oncology.

Read full article
Immatics' $125M Raise: Fueling a New Wave of Cancer Therapies
Innovation Spotlight: The Future of Business 4 months ago

Immunome's Talent Gambit: Stock Options Fuel the Cancer Drug Race

Immunome is using strategic stock grants to lure top talent. We analyze why this move is critical for its pipeline and what it means for investors.

Read full article
Immunome's Talent Gambit: Stock Options Fuel the Cancer Drug Race

Related topics in Events

Awards & Recognition178Corporate Action606Corporate Finance4484Earnings & Reporting597Funding & Investment498Industry Conference1321Regulatory & Legal2247